A Pilot Study to Assess Safety and Feasibility of Intrathecal Immunoglobulin for the Treatment of Adults with Tetanus
Authors:
- Huynh Thi LoanHLHuynh Thi Loan
- Lam Minh YenLYLam Minh Yen
- Evelyne KestelynEKEvelyne Kestelyn
- Nguyen Van HaoNHNguyen Van Hao
- Nguyen Thi Hoang MaiNMNguyen Thi Hoang Mai
- Duong Bich ThuyDTDuong Bich Thuy
- Ha Thi Hai DuongHDHa Thi Hai Duong
- Nguyen Thi Phuong DungNDNguyen Thi Phuong Dung
- Nguyen Hoan PhuNPNguyen Hoan Phu
- Pham Thi LieuPLPham Thi Lieu
- Tran Tan ThanhTTTran Tan Thanh
- Ronald GeskusRGRonald Geskus
Open Access
- 2 August 2018
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 99 (2) , 323-326
Abstract
Tetanus remains a significant burden in many low- and middle-income countries. The tetanus toxin acts within the central nervous system and intrathecal antitoxin administration may be beneficial, but there are safety concerns, especially in resource-limited settings. We performed a pilot study to assess the safety and feasibility of intrathecal human tetanus immunoglobulin in five adults with tetanus before the conduct of a large randomized controlled trial. Intrathecal injection via lumbar puncture was given to all patients within a median 140 (range 100–165) minutes of intensive care unit (ICU) admission. There were no serious adverse effects associated with the procedure although three patients had probably related minor adverse events which resolved spontaneously. Median ICU length of stay was 14 (range 5–17) days. Two patients required mechanical ventilation and one developed a deep vein thrombosis. Within 240 days of hospital discharge, no patients died and all patients returned to work.Keywords
This publication has 22 references indexed in Scilit:
- PAIN's policy on the spinal administration of drugsPain, 2010
- Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta‐analysisTropical Medicine & International Health, 2006
- Predicting the clinical outcome of tetanus: the tetanus severity scoreTropical Medicine & International Health, 2006
- Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular routeBMJ, 2004
- Post-dural puncture headache: pathogenesis, prevention and treatmentBritish Journal of Anaesthesia, 2003
- Intrathecal Therapy in TetanusJAMA, 1991
- APACHE IICritical Care Medicine, 1985
- Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanusTransactions of the Royal Society of Tropical Medicine and Hygiene, 1979
- The serum treatment of experimental tetanus in monkeysTransactions of the Royal Society of Tropical Medicine and Hygiene, 1917
- ON THE INTRATHECAL ROUTE FOR THE ADMINISTRATION OF TETANUS ANTITOXIN.The Lancet, 1917